Company & Sponsor Intelligence

Children's Hospital of Philadelphia

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting2

Completed4

Countries1

Therapeutic footprint

adhdanxietyautismepilepsyother_neurologysubstance_use

Indexed studies

NCT02651402A Hybrid Effectiveness-Implementation Trial of Group CBT in Urban Schools
anxiety · United StatesNA

NCT04294134MIO-CPP to Improve the Well-being, Permanency, and Safety Outcomes for Young Children at Risk of or in Out-of-home Placement in Philadelphia and Bucks Counties, and Affected by Maternal Substance Use
substance_use · United StatesNA

NCT07321327Implementation Strategies for Caregiver and Teacher Use of Behavioral Interventions: Aim 2
adhd · United StatesNA

NCT06555965STXBP1 and SYNGAP1 Related Disorders Natural History Study
epilepsy · United StatesRECRUITING

NCT03605368VR Intervention to Improve Police Safety
autism · United StatesNA

NCT02716324Communication to Improve Shared Decision-Making in ADHD
adhd · United StatesNA

NCT03418740Neurology Measures in FA Children
other_neurology · United StatesCOMPLETED

NCT07159308Motivation for Daily Living Skills
autism · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →